C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 417/12 (2006.01) A61K 31/426 (2006.01) A61K 31/427 (2006.01) A61P 29/00 (2006.01) A61P 31/18 (2006.01) A61P 35/00 (2006.01) C07D 277/54 (2006.01) C07D 417/14 (2006.01)
Patent
CA 2309551
Compounds of formula (I) and pharmaceutically acceptable salts thereof. As used in formula (I), and throughout the specification, the symbols have the following meanings: R1 and R2 are independently hydrogen, fluorine or alkyl; R3 is aryl or heteroaryl. The compounds of formula (I) are protein kinase inhibitors and are useful in the treatment and prevention of proliferative diseases, for example cancer, inflammation and arthritis.
On décrit des composés de la formule (I) et des sels pharmaceutiquement acceptables desdists composés. Dans ladite formule, les symboles, tels qu'ils apparaissent dans tout le descriptif, ont la signification suivante: R1 et R2 sont indépendamment hydrogène, fluor ou alkyle; R3 est aryle ou hétéroaryle. Ces composés sont des inhibiteurs de la protéine kinase et conviennent pour le traitement ou la prévention de maladies prolifératives, telles que le cancer, l'inflammation ou l'arthrose.
Cai Zhen-Wei
Han Wen-Ching
Hunt John T.
Kim Kyoung S.
Kimball S. David
Bristol-Myers Squibb Company
Gowling Lafleur Henderson Llp
LandOfFree
Aminothiazole inhibitors of cyclin dependent kinases does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Aminothiazole inhibitors of cyclin dependent kinases, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Aminothiazole inhibitors of cyclin dependent kinases will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1498871